表紙:AGE(終末糖化産物)の世界市場:業界分析、規模、シェア、成長、動向、および予測 (2021年~2031年)
市場調査レポート
商品コード
1036097

AGE(終末糖化産物)の世界市場:業界分析、規模、シェア、成長、動向、および予測 (2021年~2031年)

Advanced Glycation End Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
AGE(終末糖化産物)の世界市場:業界分析、規模、シェア、成長、動向、および予測 (2021年~2031年)
出版日: 2021年07月23日
発行: Transparency Market Research
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、世界のAGE(終末糖化産物)市場について調査しており、市場規模や予測、促進および抑制要因、機会や動向、タイプ・アプリケーション・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界のAGE(終末糖化産物)市場

第4章 市場概要

  • イントロダクション
    • タイプ定義
    • 業界の進化/発展
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界のAGE(終末糖化産物)市場分析と予測(2017-2031)

第5章 主な洞察

  • AGEとRAGEの生物活性:フローチャート
  • 主要動向分析
  • COVID-19パンデミックによる業界への影響(バリューチェーンおよび短期/中期/長期の影響)

第6章 タイプ別:世界のAGE(終末糖化産物)分析と予測

  • イントロダクションと定義
  • 主な調査結果/発展
  • 世界市場売上予測(2017-2031)
    • 非蛍光AGE
    • 蛍光AGE
  • 市場の魅力分析

第7章 アプリケーション別:世界のAGE(終末糖化産物)分析と予測

  • イントロダクションと定義
  • 主な調査結果/発展
  • 世界市場売上予測(2017-2031)
    • 糖尿病合併症
    • がん
    • 骨の疾患
    • 神経変性疾患
    • その他
  • 市場の魅力分析

第8章 エンドユーザー別:世界のAGE(終末糖化産物)分析と予測

  • イントロダクションと定義
  • 主な調査結果/発展
  • 世界市場売上予測(2017-2031)
    • 病院
    • 専門クリニック
    • その他
  • 市場の魅力分析

第9章 地域別:世界のAGE(終末糖化産物)分析と予測

  • 主な調査結果
  • 世界市場売上予測(2017-2031)
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析

第10章 北米のAGE(終末糖化産物)市場の分析と予測

  • イントロダクション
    • 主な調査結果
  • タイプ別:市場売上予測(2017-2031)
  • アプリケーション別:市場売上予測(2017-2031)
  • エンドユーザー別:市場売上予測(2017-2031)
  • 国別:市場売上予測(2017-2031)
    • 米国
    • カナダ
  • 市場の魅力分析

第11章 欧州のAGE(終末糖化産物)市場の分析と予測

第12章 アジア太平洋のAGE(終末糖化産物)市場の分析と予測

第13章 ラテンアメリカのAGE(終末糖化産物)市場の分析と予測

第14章 中東・アフリカのAGE(終末糖化産物)市場の分析と予測

第15章 競合情勢

  • 企業別:市場シェア分析(2020年)
  • 企業プロファイル
    • AbbVie, Inc.(Allergan Plc)
    • Merck KGaA
    • Takeda Pharmaceutical Company Limited
    • Estee Lauder Companies
    • Shiseido Company, Limited
    • Beiersdorf AG
    • L'Oreal SA
    • NuFACE
    • Rodan &Fields
    • PhotoMedex, Inc.
    • Ostium Cosmetics
    • Cell Biolabs, Inc.
    • Shanghai Korain Biotech Co., Ltd.
図表

List of Tables

  • Table 01: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 02: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 03: Global Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 04: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: Global Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 07: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 08: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 09: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 10: North America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 11: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 15: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 16: Europe Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 17: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 19: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 20: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 21: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 22: Asia Pacific Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 23: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 26: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 27: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 28: Latin America Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 29: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Latin America Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 31: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 33: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Non-fluorescent AGEs Type, 2017-2031
  • Table 34: Middle East & Africa Advanced Glycation End Products Market Volume (Units) Forecast, by Fluorescent AGEs Type, 2017-2031
  • Table 35: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 36: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Advanced Glycation End Products Market Value (US$ Mn) and Y-O-Y Growth (%) Forecast, 2017-2031
  • Figure 02: Global Advanced Glycation End Products Market Value Share, by Region, 2020
  • Figure 03: Global Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 04: Global Advanced Glycation End Products Market Value (US$ Mn), Non-fluorescent AGEs, 2017-2031
  • Figure 05: Global Advanced Glycation End Products Market Value (US$ Mn), Fluorescent AGEs, 2017-2031
  • Figure 06: Global Advanced Glycation End Products Market Attractiveness Analysis, by Type, 2021-2031
  • Figure 07: Global Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 08: Global Advanced Glycation End Products Market Value (US$ Mn), by Diabetic Complications, 2017-2031
  • Figure 09: Global Advanced Glycation End Products Market Value (US$ Mn), Cancer, 2017-2031
  • Figure 10: Global Advanced Glycation End Products Market Value (US$ Mn), by Bone Diseases, 2017-2031
  • Figure 11: Global Advanced Glycation End Products Market Value (US$ Mn), Neurodegenerative Diseases, 2017-2031
  • Figure 12: Global Advanced Glycation End Products Market Value (US$ Mn), by Others, 2017-2031
  • Figure 13: Global Advanced Glycation End Products Market Attractiveness Analysis, by Application, 2021-2031
  • Figure 14: Global Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 15: Global Advanced Glycation End Products Market Value (US$ Mn), by Hospitals, 2017-2031
  • Figure 16: Global Advanced Glycation End Products Market Value (US$ Mn), Specialty Clinics , 2017-2031
  • Figure 17: Global Advanced Glycation End Products Market Value (US$ Mn), by Others, 2017-2031
  • Figure 18: Global Advanced Glycation End Products Market Attractiveness Analysis, by End-user, 2021-2031
  • Figure 19: Global Advanced Glycation End Products Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 20: Global Advanced Glycation End Products Market Attractiveness Analysis, by Region
  • Figure 21: North America Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
  • Figure 22: North America Advanced Glycation End Products Market Value Share (%), by Country, 2020 and 2031
  • Figure 23: North America Advanced Glycation End Products Market Attractiveness, by Country, 2021-2031
  • Figure 24: North America Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 25: North America Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
  • Figure 26: North America Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 27: North America Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
  • Figure 28: North America Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 29: North America Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
  • Figure 30: Europe Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
  • Figure 31: Europe Advanced Glycation End Products Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 32: Europe Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 33: Europe Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 34: Europe Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
  • Figure 35: Europe Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 36: Europe Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
  • Figure 37: Europe Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 38: Europe Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
  • Figure 39: Asia Pacific Advanced Glycation End Products Market Value (US$ Mn) Forecast Projection, 2017-2031
  • Figure 40: Asia Pacific Advanced Glycation End Products Market Value Share (%), by Country, 2020 and 2031
  • Figure 41: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 42: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 43: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
  • Figure 44: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 45: Asia Pacific Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
  • Figure 46: Asia Pacific Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 47: Asia Pacific Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
  • Figure 48: Latin America Advanced Glycation End Products Market Revenue (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 49: Latin America Advanced Glycation End Products Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 50: Latin America Advanced Glycation End Products Market Attractiveness, by Country, 2021-2031
  • Figure 51: Latin America Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 52: Latin America Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
  • Figure 53: Latin America Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 54: Latin America Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
  • Figure 55: Latin America Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 56: Latin America Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
  • Figure 57: Middle East & Africa Advanced Glycation End Products Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 58: Middle East & Africa Advanced Glycation End Products Market Value Share, by Country/Sub-region, 2020-2031
  • Figure 59: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Country/Sub-region, 2021-2031
  • Figure 60: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by Type, 2020 and 2031
  • Figure 61: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Type, 2021-2031
  • Figure 62: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by Application, 2020 and 2031
  • Figure 63: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by Application, 2021-2031
  • Figure 64: Middle East & Africa Advanced Glycation End Products Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 65: Middle East & Africa Advanced Glycation End Products Market Attractiveness, by End-user, 2021-2031
目次
Product Code: TMRGL81706

Advanced Glycation End Products Market - Scope of Report

TMR's report on the global advanced glycation end products market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global advanced glycation end products market for the period from 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global advanced glycation end products market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the advanced glycation end products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global advanced glycation end products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global advanced glycation end products market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global advanced glycation end products market.

The report delves into the competitive landscape of the global advanced glycation end products market. Key players operating in the global advanced glycation end products market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global advanced glycation end products market profiled in this report.

Key Questions Answered in Advanced Glycation End Products Market Report

What is the sales/revenue generated by the advanced glycation end products market across all regions during the forecast period?

What are the opportunities in the global advanced glycation end products market?

What are the major drivers, restraints, and threats in the market?

Which regional market is set to expand at the fastest CAGR during the forecast period?

Which type segment is expected to generate the highest revenue globally in 2031?

Which segment is projected to expand at the highest CAGR during the forecast period?

What are the market positions of different companies operating in the global market?

Advanced Glycation End Products Market - Research Objectives and Research Approach

The comprehensive report on the global advanced glycation end products market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global advanced glycation end products market in terms of type, application, end user, and region. Key segments under each criterion are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global advanced glycation end products market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Advanced Glycation End Products Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Advanced Glycation End Products Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Bioactivity of AGEs and RAGE: Flowchart
  • 5.2. Key Trend Analysis
  • 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)

6. Global Advanced Glycation End Products Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 6.3.1. Non-fluorescent AGEs
      • 6.3.1.1. Carboxymethyl-lysine (CML)
      • 6.3.1.2. Carboxyethyl-lysine (CEL)
      • 6.3.1.3. Pyrraline
    • 6.3.2. Fluorescent AGEs
      • 6.3.2.1. Pentosidine
      • 6.3.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 6.4. Global Advanced Glycation End Products Market Attractiveness, by Type

7. Global Advanced Glycation End Products Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Diabetic Complications
    • 7.3.2. Cancer
    • 7.3.3. Bone Diseases
    • 7.3.4. Neurodegenerative Diseases
    • 7.3.5. Others
  • 7.4. Global Advanced Glycation End Products Market Attractiveness, by Application

8. Global Advanced Glycation End Products Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Global Advanced Glycation End Products Market Attractiveness, by End-user

9. Global Advanced Glycation End Products Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Advanced Glycation End Products Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Advanced Glycation End Products Market Attractiveness, by Country/Region

10. North America Advanced Glycation End Products Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 10.2.1. Non-fluorescent AGEs
      • 10.2.1.1. Carboxymethyl-lysine (CML)
      • 10.2.1.2. Carboxyethyl-lysine (CEL)
      • 10.2.1.3. Pyrraline
    • 10.2.2. Fluorescent AGEs
      • 10.2.2.1. Pentosidine
      • 10.2.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 10.3. North America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Diabetic Complications
    • 10.3.2. Cancer
    • 10.3.3. Bone Diseases
    • 10.3.4. Neurodegenerative Diseases
    • 10.3.5. Others
  • 10.4. North America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Clinics
    • 10.4.3. Others
  • 10.5. North America Advanced Glycation End Products Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Advanced Glycation End Products Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Advanced Glycation End Products Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Europe Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 11.2.1. Non-fluorescent AGEs
      • 11.2.1.1. Carboxymethyl-lysine (CML)
      • 11.2.1.2. Carboxyethyl-lysine (CEL)
      • 11.2.1.3. Pyrraline
    • 11.2.2. Fluorescent AGEs
      • 11.2.2.1. Pentosidine
      • 11.2.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 11.3. Europe Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Diabetic Complications
    • 11.3.2. Cancer
    • 11.3.3. Bone Diseases
    • 11.3.4. Neurodegenerative Diseases
    • 11.3.5. Others
  • 11.4. Europe Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Specialty Clinics
    • 11.4.3. Others
  • 11.5. Europe Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Europe Advanced Glycation End Products Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Advanced Glycation End Products Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 12.2.1. Non-fluorescent AGEs
      • 12.2.1.1. Carboxymethyl-lysine (CML)
      • 12.2.1.2. Carboxyethyl-lysine (CEL)
      • 12.2.1.3. Pyrraline
    • 12.2.2. Fluorescent AGEs
      • 12.2.2.1. Pentosidine
      • 12.2.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 12.3. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Diabetic Complications
    • 12.3.2. Cancer
    • 12.3.3. Bone Diseases
    • 12.3.4. Neurodegenerative Diseases
    • 12.3.5. Others
  • 12.4. Asia Pacific Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Specialty Clinics
    • 12.4.3. Others
  • 12.5. Asia Pacific Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Asia Pacific Advanced Glycation End Products Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Advanced Glycation End Products Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Latin America Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 13.2.1. Non-fluorescent AGEs
      • 13.2.1.1. Carboxymethyl-lysine (CML)
      • 13.2.1.2. Carboxyethyl-lysine (CEL)
      • 13.2.1.3. Pyrraline
    • 13.2.2. Fluorescent AGEs
      • 13.2.2.1. Pentosidine
      • 13.2.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 13.3. Latin America Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Diabetic Complications
    • 13.3.2. Cancer
    • 13.3.3. Bone Diseases
    • 13.3.4. Neurodegenerative Diseases
    • 13.3.5. Others
  • 13.4. Latin America Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Specialty Clinics
    • 13.4.3. Others
  • 13.5. Latin America Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Latin America Advanced Glycation End Products Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Advanced Glycation End Products Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Type, 2017-2031
    • 14.2.1. Non-fluorescent AGEs
      • 14.2.1.1. Carboxymethyl-lysine (CML)
      • 14.2.1.2. Carboxyethyl-lysine (CEL)
      • 14.2.1.3. Pyrraline
    • 14.2.2. Fluorescent AGEs
      • 14.2.2.1. Pentosidine
      • 14.2.2.2. Methylglyoxal-lysine dimer (MOLD)
  • 14.3. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Diabetic Complications
    • 14.3.2. Cancer
    • 14.3.3. Bone Diseases
    • 14.3.4. Neurodegenerative Diseases
    • 14.3.5. Others
  • 14.4. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Specialty Clinics
    • 14.4.3. Others
  • 14.5. Middle East & Africa Advanced Glycation End Products Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Advanced Glycation End Products Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Share Analysis, by Company (2020)
  • 15.2. Company Profiles
    • 15.2.1. AbbVie, Inc. (Allergan Plc)
      • 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.1.2. Company Financials
      • 15.2.1.3. Growth Strategies
      • 15.2.1.4. SWOT Analysis
    • 15.2.2. Merck KGaA
      • 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.2.2. Company Financials
      • 15.2.2.3. Growth Strategies
      • 15.2.2.4. SWOT Analysis
    • 15.2.3. Takeda Pharmaceutical Company Limited
      • 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.3.2. Company Financials
      • 15.2.3.3. Growth Strategies
      • 15.2.3.4. SWOT Analysis
    • 15.2.4. Estee Lauder Companies
      • 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.4.2. Company Financials
      • 15.2.4.3. Growth Strategies
      • 15.2.4.4. SWOT Analysis
    • 15.2.5. Shiseido Company, Limited
      • 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.5.2. Company Financials
      • 15.2.5.3. Growth Strategies
      • 15.2.5.4. SWOT Analysis
    • 15.2.6. Beiersdorf AG
      • 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.6.2. Company Financials
      • 15.2.6.3. Growth Strategies
      • 15.2.6.4. SWOT Analysis
    • 15.2.7. L'Oreal S.A.
      • 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.7.2. Company Financials
      • 15.2.7.3. Growth Strategies
      • 15.2.7.4. SWOT Analysis
    • 15.2.8. NuFACE
      • 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.8.2. Company Financials
      • 15.2.8.3. Growth Strategies
      • 15.2.8.4. SWOT Analysis
    • 15.2.9. Rodan & Fields
      • 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.9.2. Company Financials
      • 15.2.9.3. Growth Strategies
      • 15.2.9.4. SWOT Analysis
    • 15.2.10. PhotoMedex, Inc.
      • 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.10.2. Company Financials
      • 15.2.10.3. Growth Strategies
      • 15.2.10.4. SWOT Analysis
    • 15.2.11. Ostium Cosmetics
      • 15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.11.2. Company Financials
      • 15.2.11.3. Growth Strategies
      • 15.2.11.4. SWOT Analysis
    • 15.2.12. Cell Biolabs, Inc.
      • 15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.12.2. Company Financials
      • 15.2.12.3. Growth Strategies
      • 15.2.12.4. SWOT Analysis
    • 15.2.13. Shanghai Korain Biotech Co., Ltd.
      • 15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.2.13.2. Company Financials
      • 15.2.13.3. Growth Strategies
      • 15.2.13.4. SWOT Analysis